# Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

> **NCT06430411** · — · NOT_YET_RECRUITING · sponsor: **Medical University of Vienna** · enrollment: 500 (estimated)

## Conditions studied

- Prostate Cancer Metastatic
- Prostate Cancer Metastatic to Bone
- Prostate Cancer
- Prostate Neoplasm
- Oligometastatic Disease
- Oligometastasis

## Interventions

- **PROCEDURE:** Radical prostatectomy
- **RADIATION:** Prostate irradiation
- **PROCEDURE:** Surgical metastasectomy
- **RADIATION:** Irradiation of metastases
- **DRUG:** Abiraterone acetate
- **DRUG:** Enzalutamide
- **DRUG:** Darolutamide
- **DRUG:** Apalutamide
- **DRUG:** Docetaxel
- **DRUG:** Lutetium-PSMA
- **DRUG:** Androgen deprivation treatment

## Key facts

- **NCT ID:** NCT06430411
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-31
- **Primary completion:** 2031-01-01
- **Final completion:** 2031-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-05-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06430411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06430411, "Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06430411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*